Wyeth (WYE) is unexpectedly facing generic competition for its top drugs, most notably its blockbuster heartburn treatment Protonix. Generic Protonix is expected to contribute to flat sales and a pos
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The U.S. Food and Drug Administration licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals, almost exclusively males, in the
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Wyeth said Friday it has ended its partnership with Solvay Pharmaceuticals to develop and market bifeprunox and other early-stage compounds as treatments for schizophrenia and other psychiatric condi
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The European Medicines Agency (EMEA) has been formally notified by Wyeth Europa Ltd of its decision to withdraw the application for a centralised marketing authorisation for the medicine Pristiqs (de
read more » Discuss Add this link to...Bury Add to:
| Bookmarks